Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slirp | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLIRP mRNA | CTD | PMID:22206623 | Slirp | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression more ... | CTD | PMID:37844793 | Slirp | Rat | 17beta-estradiol | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Estradiol results in decreased expression of SLIRP mRNA | CTD | PMID:23019147 | Slirp | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Slirp (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLIRP mRNA | CTD | PMID:31388691 | Slirp | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLIRP mRNA | CTD | PMID:33387578 | Slirp | Rat | 3',5'-cyclic UMP | affects binding | ISO | SLIRP (Homo sapiens) | 6480464 | SLIRP protein binds to cyclic 3',5'-uridine monophosphate | CTD | PMID:30528433 | Slirp | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Slirp (Mus musculus) | 6480464 | bisphenol S results in increased expression of SLIRP mRNA | CTD | PMID:39298647 | Slirp | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | Slirp | Rat | aflatoxin B1 | decreases methylation | ISO | SLIRP (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SLIRP gene | CTD | PMID:27153756 | Slirp | Rat | all-trans-retinoic acid | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SLIRP mRNA | CTD | PMID:21934132 | Slirp | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | Slirp | Rat | arsane | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slirp | Rat | arsenic atom | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slirp | Rat | arsenite(3-) | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to SLIRP mRNA] | CTD | PMID:32406909 | Slirp | Rat | arsenite(3-) | increases expression | ISO | Slirp (Mus musculus) | 6480464 | arsenite results in increased expression of SLIRP protein | CTD | PMID:37955338 | Slirp | Rat | beta-lapachone | increases expression | ISO | SLIRP (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of SLIRP mRNA | CTD | PMID:38218311 | Slirp | Rat | beta-lapachone | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of SLIRP mRNA | CTD | PMID:38218311 | Slirp | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of SLIRP mRNA | CTD | PMID:33754040 | Slirp | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLIRP mRNA | CTD | PMID:25181051 | Slirp | Rat | bisphenol A | increases expression | ISO | Slirp (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLIRP mRNA | CTD | PMID:33221593 | Slirp | Rat | bisphenol A | decreases expression | ISO | Slirp (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SLIRP mRNA | CTD | PMID:30245210 | Slirp | Rat | bisphenol A | affects expression | ISO | SLIRP (Homo sapiens) | 6480464 | bisphenol A affects the expression of SLIRP mRNA | CTD | PMID:30903817 | Slirp | Rat | bisphenol A | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SLIRP mRNA | CTD | PMID:38568856 | Slirp | Rat | bisphenol F | decreases expression | ISO | Slirp (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SLIRP mRNA | CTD | PMID:38685157 | Slirp | Rat | Butylbenzyl phthalate | decreases expression | ISO | Slirp (Mus musculus) | 6480464 | butylbenzyl phthalate results in decreased expression of SLIRP mRNA | CTD | PMID:32308655 | Slirp | Rat | carbon nanotube | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of SLIRP mRNA | CTD | PMID:25554681 | Slirp | Rat | chloropicrin | increases expression | ISO | SLIRP (Homo sapiens) | 6480464 | chloropicrin results in increased expression of SLIRP mRNA | CTD | PMID:26352163 | Slirp | Rat | cobalt dichloride | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of SLIRP mRNA | CTD | PMID:19376846 | Slirp | Rat | copper(II) sulfate | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SLIRP mRNA | CTD | PMID:19549813 | Slirp | Rat | crocidolite asbestos | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Asbestos, Crocidolite results in increased expression of SLIRP mRNA | CTD | PMID:29279043 | Slirp | Rat | DDE | increases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of SLIRP mRNA | CTD | PMID:38568856 | Slirp | Rat | diclofenac | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression more ... | CTD | PMID:37844793 | Slirp | Rat | epoxiconazole | increases expression | ISO | Slirp (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SLIRP mRNA | CTD | PMID:35436446 | Slirp | Rat | eugenol | decreases expression | EXP | | 6480464 | Eugenol results in decreased expression of SLIRP protein | CTD | PMID:39793947 | Slirp | Rat | fenthion | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Fenthion results in increased expression of SLIRP mRNA | CTD | PMID:34813904 | Slirp | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of SLIRP mRNA | CTD | PMID:30307764 | Slirp | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of SLIRP mRNA | CTD | PMID:23962444 | Slirp | Rat | folic acid | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLIRP mRNA | CTD | PMID:22206623 | Slirp | Rat | FR900359 | increases phosphorylation | ISO | SLIRP (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of SLIRP protein | CTD | PMID:37730182 | Slirp | Rat | gold atom | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Gold results in decreased expression of SLIRP mRNA | CTD | PMID:25523186 | Slirp | Rat | gold(0) | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Gold results in decreased expression of SLIRP mRNA | CTD | PMID:25523186 | Slirp | Rat | hydralazine | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SLIRP mRNA | CTD | PMID:17183730 | Slirp | Rat | ibuprofen | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression more ... | CTD | PMID:37844793 | Slirp | Rat | inulin | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLIRP mRNA | CTD | PMID:36331819 | Slirp | Rat | ivermectin | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SLIRP protein | CTD | PMID:32959892 | Slirp | Rat | lead(0) | affects expression | ISO | SLIRP (Homo sapiens) | 6480464 | Lead affects the expression of SLIRP mRNA | CTD | PMID:28903495 | Slirp | Rat | lipopolysaccharide | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of SLIRP mRNA | CTD | PMID:35877022 | Slirp | Rat | manganese atom | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slirp | Rat | manganese(0) | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slirp | Rat | manganese(II) chloride | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slirp | Rat | methidathion | increases expression | ISO | Slirp (Mus musculus) | 6480464 | methidathion results in increased expression of SLIRP mRNA | CTD | PMID:34813904 | Slirp | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | Slirp | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SLIRP mRNA | CTD | PMID:25729387 | Slirp | Rat | ozone | increases phosphorylation | EXP | | 6480464 | Ozone results in increased phosphorylation of SLIRP protein | CTD | PMID:33146391 | Slirp | Rat | ozone | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLIRP mRNA | CTD | PMID:35430440 | Slirp | Rat | ozone | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... | CTD | PMID:34911549 | Slirp | Rat | paracetamol | affects expression | ISO | SLIRP (Homo sapiens) | 6480464 | Acetaminophen affects the expression of SLIRP mRNA | CTD | PMID:25704631 | Slirp | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLIRP mRNA | CTD | PMID:36331819 | Slirp | Rat | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | Slirp | Rat | resveratrol | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SLIRP mRNA | CTD | PMID:23557933 | Slirp | Rat | SB 431542 | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SLIRP more ... | CTD | PMID:37664457 | Slirp | Rat | sodium arsenite | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SLIRP mRNA | CTD | PMID:38568856 | Slirp | Rat | sodium arsenite | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slirp | Rat | sodium arsenite | increases expression | ISO | SLIRP (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SLIRP mRNA | CTD | PMID:34032870 | Slirp | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | Slirp | Rat | tetrachloromethane | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SLIRP mRNA | CTD | PMID:31919559 | Slirp | Rat | thiram | decreases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Thiram results in decreased expression of SLIRP mRNA | CTD | PMID:38568856 | Slirp | Rat | toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of SLIRP mRNA | CTD | PMID:22967744 | Slirp | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SLIRP mRNA | CTD | PMID:25729387 | Slirp | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of SLIRP mRNA | CTD | PMID:33387578 | Slirp | Rat | triphenyl phosphate | affects expression | ISO | SLIRP (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SLIRP mRNA | CTD | PMID:37042841 | Slirp | Rat | tungsten | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Tungsten results in increased expression of SLIRP mRNA | CTD | PMID:30912803 | Slirp | Rat | valproic acid | multiple interactions | ISO | SLIRP (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SLIRP mRNA | CTD | PMID:17183730 | Slirp | Rat | valproic acid | increases expression | ISO | SLIRP (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLIRP mRNA; Valproic Acid results in increased expression more ... | CTD | PMID:29501571 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















